US2018119092A1PendingUtilityA1

Hydrogel precursor formulation and production process thereof

61
Assignee: QGEL SAPriority: Apr 22, 2010Filed: Dec 19, 2017Published: May 3, 2018
Est. expiryApr 22, 2030(~3.8 yrs left)· nominal 20-yr term from priority
C08G 65/3344C12N 2533/50C12N 5/0068C12N 2533/30C08G 75/04
61
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A hydrogel precursor formulation, its process of production as well as a kit comprising the formulation and a method of production of a hydrogel using the formulation. The precursor formulation comprises at least one structural compound, preferably vinyl sulfone (acrylated branched) poly(ethylene glycol), and at least one linker compound, preferably a peptide with two cysteines. The structural compound and the linker compound are polymerizable by a selective reaction between a nucleophile and a conjugated unsaturated bond or group. The precursor formulation is in the form of a powder.

Claims

exact text as granted — not AI-modified
1 - 22 . (canceled) 
     
     
         23 . A process for production of a hydrogel precursor formulation in form of a powder, the process comprising:
 providing a first solution A of at least one structural compound, wherein the structural compound has conjugated unsaturated bond or groups;   providing a second solution B comprising at least one linker compound, wherein the linker compound comprises at least two nucleophilic groups;   mixing of the solutions A and B under conditions which hinder a selective reaction between the unsaturated bond or group and the nucleophile resulting in a precursor solution; and   lyophilization of the resulting precursor solution to an unreacted powder,   wherein the unreacted powder comprises the at least one structural compound and the at least one linker compound, which are polymerizable by a selective reaction between the nucleophile and the conjugated unsaturated bond or group.   
     
     
         24 . The process according to  claim 23 , further comprising mixing the solutions A and B at a pH of 4.0 or below. 
     
     
         25 . The process according to  claim 23 , further comprising forming the solution A to comprise 5-10% w/v of the at least one structural compound. 
     
     
         26 . The process according to  claim 23 , further comprising forming the solution B to comprise 0.1-2% w/v of the at least one linker compound. 
     
     
         27 . The process according to  claim 23 , further comprising forming a solution C to comprise at least one biologically active compound which is dimerizable with the structural compound by the selective reaction between the nucleophile and the conjugated unsaturated bond or group is added to the solution A prior to the mixing of the solutions A and B. 
     
     
         28 . The process according to  claim 27 , further comprising forming the solution C to comprise 0.1-10% w/v of the at least one active compound. 
     
     
         29 . The process according to  claim 27 , further comprising forming at least one of the solution A, the solution B and the solution C as a solution of the at least one structural compound, the at least one linker compound or the at least one biologically active compound in distilled water. 
     
     
         30 . The process according to  claim 23 , further comprising selecting the concentration of the at least one structural compound and the at least one linker compounds such that a molar ratio of the nucleophile to the conjugated unsaturated bond or group is in a range of 0.8:1 to 1.3:1. 
     
     
         31 . The process according to  claim 23 , further comprising subjecting the precursor solution to filtration prior to the lyophilization step. 
     
     
         32 . The process according to  claim 23 , further comprising aliquoting the precursor solution and filling into containers before the lyophilization step. 
     
     
         33 . The process according to  claim 32 , further comprising filling the containers with sterile nitrogen gas and immediately capping after the lyophilization step. 
     
     
         34 . A kit of parts comprising at least one container filled with a hydrogel precursor formulation comprising at least one structural compound and at least one linker compound,
 wherein said structural compound and said linker compound are polymerizable by a selective reaction between a nucleophile and a conjugated unsaturated bond or group, the hydrogel precursor formulation is in the form of an unreacted powder, said unreacted powder is in the form of a stable compact cake, and a container with a reaction buffer.   
     
     
         35 . The kit of parts according to  claim 34 , wherein the reaction buffer has a pH of at least 7. 
     
     
         38 . A method of production of a hydrogel comprising:
 providing the hydrogel precursor formulation of  claim 23  comprising the at least one structural compound and the at least one linker compound in at least one container, wherein said structural compound and said linker compound are polymerizable by a selective reaction between a nucleophile and a conjugated bond or group, and the hydrogel precursor formulation is in the form of an unreacted powder;   re-suspending the hydrogel precursor formulation in a buffer having a pH of between 7 and 8;   casting a gel precursor with the hydrogel precursor formulation re-suspension; and   allowing polymerization of the gel precursor for at least 30 minutes, to form a hydrogel.   
     
     
         37 . The method of production of a hydrogel according to claim  36  further comprising the step of adding a cell culture suspension to the precursor suspension. 
     
     
         38 . The method of production of a hydrogel according to claim  36 , further comprising the step of performing polymerization in an incubator at 37° C. 
     
     
         39 . A hydrogel precursor formulation obtainable by the process according to  claim 23 .

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.